Related Experiment Video
Updated: Jan 22, 2026

Profiling of Estrogen-regulated MicroRNAs in Breast Cancer Cells
Published on: February 21, 2014
MicroRNA Regulation of Epigenetic Modifiers in Breast Cancer
Brock Humphries1, Zhishan Wang2, Chengfeng Yang3,4
1Center for Molecular Imaging, Department of Radiology, University of Michigan, Ann Arbor, MI 48109; USA. brhu@med.umich.edu.
Abstract:
Epigenetics refers to the heritable changes in gene expression without a change in the DNA sequence itself. Two of these major changes include aberrant DNA methylation as well as changes to histone modification patterns. Alterations to the epigenome can drive expression of oncogenes and suppression of tumor suppressors, resulting in tumorigenesis and cancer progression. In addition to modifications of the epigenome, microRNA (miRNA) dysregulation is also a hallmark for cancer initiation and metastasis. Advances in our understanding of cancer biology demonstrate that alterations in the epigenome are not only a major cause of miRNA dysregulation in cancer, but that miRNAs themselves also indirectly drive these DNA and histone modifications. More explicitly, recent work has shown that miRNAs can regulate chromatin structure and gene expression by directly targeting key enzymes involved in these processes. This review aims to summarize these research findings specifically in the context of breast cancer. This review also discusses miRNAs as epigenetic biomarkers and as therapeutics, and presents a comprehensive summary of currently validated epigenetic targets in breast cancer.
Insights
Epigenetic alterations, including DNA methylation and histone modifications, drive breast cancer by affecting gene expression. MicroRNAs (miRNAs) are also dysregulated and can influence these epigenetic changes, serving as potential biomarkers and therapeutics.
Area of Science:
- Molecular Biology
- Cancer Biology
- Genetics
Background:
- Epigenetics involves heritable gene expression changes without altering DNA sequence.
- Aberrant DNA methylation and histone modifications are key epigenetic changes in cancer.
- MicroRNA (miRNA) dysregulation is a hallmark of cancer initiation and metastasis.
Purpose of the Study:
- To review epigenetic alterations and miRNA dysregulation in breast cancer.
- To explore the interplay between epigenetics and miRNAs in breast cancer development.
- To discuss miRNAs as epigenetic biomarkers and therapeutic targets in breast cancer.
Main Methods:
- Literature review of epigenetic mechanisms in breast cancer.
- Analysis of miRNA's role in regulating epigenetic modifications.
- Summary of validated epigenetic targets in breast cancer.
Main Results:
- Epigenomic alterations drive oncogene expression and tumor suppressor silencing in breast cancer.
- miRNAs are both affected by and contribute to epigenetic dysregulation in cancer.
- miRNAs can directly target enzymes involved in chromatin structure and gene expression.
Conclusions:
- The intricate relationship between epigenetics and miRNAs is crucial in breast cancer.
- miRNAs hold promise as epigenetic biomarkers and therapeutic agents for breast cancer.
- Targeting epigenetic modifications presents a viable strategy for breast cancer treatment.
Related Concept Videos
Epigenetic Regulation
Epigenetic Regulation
X-chromosome...
MicroRNAs
MicroRNAs
Regulation of Expression Occurs at Multiple Steps
Transcription results in the generation of precursor (pre-mRNA) that consists of both exons and introns, which needs further processing before being translated to a...
lncRNA - Long Non-coding RNAs

